ABBOTT LABORATORIES — Director's Dealing 2007

Mar 5, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-03-01

Reporting Person: Landgraf John C (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-03-01	Common shares without par value	M	3529	$37.4229	Acquired	117285	Direct
2007-03-01	Common shares without par value	S	3529	$54.538	Disposed	113756	Direct
2007-03-01	Common shares without par value	S	17000	$54.008	Disposed	96756	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-03-01	Option (right to buy)	$37.4229	M	3529	Disposed	2007-03-30	common shares (3529)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	15224	Indirect
Common shares without par value	25000	Indirect
Common shares without par value	880	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of March 5, 2007.

F2: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.

F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.

F4: Reporting person disclaims beneficial ownership of all securities held by his son.

F5: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.